This is a Validated Antibody Database (VAD) review about human IL 23, based on 6 published articles (read how Labome selects the articles), using IL 23 antibody in all methods. It is aimed to help Labome visitors find the most suited IL 23 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IL 23 synonym: IL-23; IL-23A; IL23P19; P19; SGRF; interleukin-23 subunit alpha; IL-23 subunit alpha; IL-23-A; IL-23p19; JKA3 induced upon T-cell activation; interleukin 23 p19 subunit; interleukin 23, alpha subunit p19; interleukin-23 subunit p19; interleukin-six, G-CSF related factor
Abcam
rabbit polyclonal |
| Abcam IL 23 antibody (Abcam, ab45420) was used in immunohistochemistry - paraffin section on mouse samples (fig s4a). Cell (2017) ncbi |
rabbit polyclonal |
| Abcam IL 23 antibody (Abcam, ab45420) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2013) ncbi |
rabbit polyclonal |
| Abcam IL 23 antibody (Abcam, ab45420) was used in immunohistochemistry - paraffin section on mouse samples . J Invest Dermatol (2013) ncbi |
Invitrogen
mouse monoclonal (HNU2319) |
| Invitrogen IL 23 antibody (eBioscience, HNU2319) was used in blocking or activating experiments on human samples (fig 3d). Eur J Immunol (2016) ncbi |
mouse monoclonal (HNU2319) |
| Invitrogen IL 23 antibody (eBioscience, HNU2319) was used in blocking or activating experiments on human samples . Eur J Immunol (2015) ncbi |
ProSci
rabbit polyclonal |
| In order to study changes in IL-23 and IL-22 after scratching, ProSci IL 23 antibody (ProSci incorporated, 3795) was used in immunohistochemistry - paraffin section on mouse samples (fig 5d). J Exp Med (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments